Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2/3 1 Phase 1 1

Status

Completed 7 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 49 fludarabine 37 Injections 32 Gemcitabine 24 Paclitaxel 23 Cisplatin 21 pembrolizumab 19 Radiotherapy 19 toripalimab 18 Carboplatin 17 Capecitabine 17 Fluorouracil 15 Oxaliplatin 13 Nivolumab 12 Docetaxel 12 camrelizumab 11 apatinib 11 Temozolomide 11 Cetuximab 11 Bevacizumab 10 Irinotecan 9 Immunotherapy, Adoptive 9 Drug Therapy 9 Etoposide 8 sintilimab 7 Radiosurgery 7 Peripheral Blood Stem Cell Transplantation 7 Leucovorin 7 Ipilimumab 7 Indium 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Unknown × oblimersen × Clear all

NCT00409383 2011-11-07

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Genta Incorporated

Phase 1 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡